Edition:
United Kingdom

People: Galapagos NV (GLPG.AS)

GLPG.AS on Amsterdam Stock Exchange

146.80EUR
13 Sep 2019
Change (% chg)

€1.40 (+0.96%)
Prev Close
€145.40
Open
€145.00
Day's High
€146.80
Day's Low
€143.25
Volume
220,573
Avg. Vol
375,371
52-wk High
€171.20
52-wk Low
€74.48

Hoekema, Andre 

Dr. Andre Hoekema, Ph.D. is Member of the Executive Committee, Chief Business Officer at Galapagos NV. He joined Galapagos in March 2005 from Invitrogen Corporation, where he was Managing Director of Corporate Development Europe. He has 20 years of biotech experience from positions at Molecular Probes Europe (Managing Director), Crucell (Director of Business Development), DSM Life Sciences and MOGEN (Research and Project Management) and Genentech, Inc. Dr. Hoekema has a Doctorate in Philosophy degree from Leiden University and is the inventor of over 20 series of patent applications, resulting in 15 patents issued in the United States. Dr. Hoekema currently also serves as a member of the supervisory board of Mimetas B.V. and has previously served as a member of the supervisory board of VitalNext B.V.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --